» Articles » PMID: 37583716

Partial Genome Content Within RAAVs Impacts Performance in a Cell Assay-dependent Manner

Overview
Publisher Cell Press
Date 2023 Aug 16
PMID 37583716
Authors
Affiliations
Soon will be listed here.
Abstract

Recombinant adeno-associated viruses (rAAVs) deliver DNA to numerous cell types. However, packaging of partial genomes into the rAAV capsid is of concern. Although empty rAAV capsids are studied, there is little information regarding the impact of partial DNA content on rAAV performance in controlled studies. To address this, we tested vectors containing varying levels of partial, self-complementary genomes. Density gradient cesium chloride ultracentrifugation was used to isolate three distinct rAAV populations: (1) a lighter fraction, (2) a moderate fraction, and (3) a heavy fraction. Alkaline gels, Illumina Mi-Seq, size exclusion chromatography with multi-angle light scattering (SEC-MALS), and charge detection mass spectrometry (CD-MS) were used to characterize the genome of each population and ddPCR to quantify residual DNA molecules. Live-cell imaging and EGFP ELISA assays demonstrated reduced expression following transduction with the light fraction compared with the moderate and heavy fractions. However, PCR-based assays showed that the light density delivered DNA to cells as efficiently as the moderate and heavy fractions. Mi-Seq data revealed an underrepresentation of the promoter region for , suggesting that expression of EGFP was reduced because of lack of regulatory control. This work demonstrates that rAAVs containing partial genomes contribute to the DNA signal but have reduced vector performance.

Citing Articles

An improved high-resolution method for quantitative separation of empty and filled AAV8 capsids by strong anion exchange HPLC.

Schrecke S, McManus K, Moshfegh C, Stone J, Nguyen T, Rivas G Front Bioeng Biotechnol. 2024; 12:1436857.

PMID: 39411057 PMC: 11473411. DOI: 10.3389/fbioe.2024.1436857.


In-Depth Comparison of Adeno-Associated Virus Containing Fractions after CsCl Ultracentrifugation Gradient Separation.

Janc M, Zevnik K, Dolinar A, Jakomin T, Stalekar M, Bacnik K Viruses. 2024; 16(8).

PMID: 39205208 PMC: 11360810. DOI: 10.3390/v16081235.


Thorough molecular configuration analysis of noncanonical AAV genomes in AAV vector preparations.

Zhang J, Yu X, Chrzanowski M, Tian J, Pouchnik D, Guo P Mol Ther Methods Clin Dev. 2024; 32(1):101215.

PMID: 38463141 PMC: 10924063. DOI: 10.1016/j.omtm.2024.101215.

References
1.
Lock M, Alvira M, Vandenberghe L, Samanta A, Toelen J, Debyser Z . Rapid, simple, and versatile manufacturing of recombinant adeno-associated viral vectors at scale. Hum Gene Ther. 2010; 21(10):1259-71. PMC: 2957274. DOI: 10.1089/hum.2010.055. View

2.
Dismuke D, Tenenbaum L, Samulski R . Biosafety of recombinant adeno-associated virus vectors. Curr Gene Ther. 2013; 13(6):434-52. DOI: 10.2174/15665232113136660007. View

3.
Gao G, Qu G, BURNHAM M, Huang J, Chirmule N, Joshi B . Purification of recombinant adeno-associated virus vectors by column chromatography and its performance in vivo. Hum Gene Ther. 2000; 11(15):2079-91. DOI: 10.1089/104303400750001390. View

4.
Stanley P, Narasimhan S, Siminovitch L, SCHACHTER H . Chinese hamster ovary cells selected for resistance to the cytotoxicity of phytohemagglutinin are deficient in a UDP-N-acetylglucosamine--glycoprotein N-acetylglucosaminyltransferase activity. Proc Natl Acad Sci U S A. 1975; 72(9):3323-7. PMC: 432984. DOI: 10.1073/pnas.72.9.3323. View

5.
Joshi P, Bernier A, Moco P, Schrag J, Chahal P, Kamen A . Development of a scalable and robust AEX method for enriched rAAV preparations in genome-containing VCs of serotypes 5, 6, 8, and 9. Mol Ther Methods Clin Dev. 2021; 21:341-356. PMC: 8056178. DOI: 10.1016/j.omtm.2021.03.016. View